Related Experiment Video
Updated: Jun 3, 2026

Iris Fixation via External Pentagram Suturing
Published on: May 5, 2022
[Clinical observation of posterior polymorphous corneal dystrophy]
Chen-Jiu Pang1, Yang Jing, Jin Li
1Henan Eye Institute, Zhengzhou 450003, China. pangcj999@sohu.com
Posterior polymorphous corneal dystrophy (PPCD) presents with varied lesions and abnormal corneal topography. Advanced imaging like specular microscopy and in vivo confocal microscopy are crucial for diagnosis.
Area of Science:
- Ophthalmology
- Corneal Diseases
- Microscopy
Context:
- Posterior polymorphous corneal dystrophy (PPCD) is a rare genetic eye condition.
- Understanding its clinical features and microscopic findings is essential for diagnosis and management.
Purpose:
- To investigate the clinical manifestations and in vivo confocal microscopic characteristics of posterior polymorphous corneal dystrophy (PPCD).
Summary:
- This study analyzed 10 patients with PPCD, detailing their ages, lesion types (vesicular, band-like, diffused opacities), and associated complications like iridocorneal adhesions.
- Specular microscopy revealed significantly larger endothelial cells and reduced density in affected eyes compared to normal eyes.
- In vivo confocal microscopy identified endothelial polymorphism, bright nuclei, and various lesions such as finger-like projections and dike-like appearances.
Impact:
- The findings emphasize the importance of slit-lamp examination for initial PPCD diagnosis, with specular microscopy and in vivo confocal microscopy providing confirmation.
- Abnormal corneal topography and potential association with elevated intraocular pressure were noted, highlighting the need for comprehensive ophthalmic evaluation.
More Related Videos
04:48Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures
Published on: November 22, 2024
12:36A Human Corneal Organ Culture Model of Descemet's Stripping Only with Accelerated Healing Stimulated by Engineered Fibroblast Growth Factor 1
Published on: July 22, 2022